BRIEF published on 10/12/2026 at 07:35, 5 days 20 hours ago Advicenne extends its cash reserves until 2028 Treasury Funding Sales Performance Nephrology Advicenna
BRIEF published on 10/12/2026 at 07:35, 5 days 20 hours ago Advicenne Secures Financial Stability with Extended Runway to 2028 Product Sales Bond Financing Advicenne Financial Runway Share Dilution Risks
PRESS RELEASE published on 10/12/2026 at 07:30, 5 days 20 hours ago Inside Information / Other news releases Advicenne extends financial visibility to 2028 thanks to bond financing and strong sales performance in neurology and nephrology Neurology Bond Financing Advicenne Nephrology Financial Visibility
BRIEF published on 09/28/2026 at 14:40, 19 days 13 hours ago Advicenne publishes its monthly voting rights figures Share Capital Voting Rights AMF Share Issuance Advicenna
BRIEF published on 08/31/2026 at 07:05, 1 month 17 days ago Advicenne withdraws the application for registration of ADV7103 in the United States FDA Pharmaceutical Registration Advicenna Sibnayal
PRESS RELEASE published on 08/31/2026 at 07:00, 1 month 17 days ago Inside Information / Other news releases Advicenne voluntarily withdraws NDA for ADV7103 in the USA due to CMC-related work issues. Company hosting French webinar for shareholders. ADV7103 approved in EU, UK, KSA, UAE Pharmaceutical Webinar Advicenne ADV7103 NDA Withdrawal
BRIEF published on 07/16/2026 at 18:40, 3 months 1 day ago Advicenne's Revenue Surge in First Half of 2026 Revenue Growth Advicenne Sibnayal® Likozam® Pharmaceutical Sales
PRESS RELEASE published on 07/16/2026 at 18:35, 3 months 1 day ago Inside Information / Other news releases Advicenne reports significant revenue growth in first half of 2026 driven by Sibnayal® and Likozam® reimbursement in France, ending negative impact of early access rebates. Sales of Sibnayal® and Likozam® increased in volume Revenue Growth France Advicenne Sibnayal® Likozam®
BRIEF published on 07/01/2026 at 17:50, 3 months 16 days ago Unlimited renewal of the marketing authorization for Sibnayal® by Advicenne in the United Kingdom United Kingdom Advicenna Sibnayal Rare Kidney Diseases Marketing Authorization Renewal
BRIEF published on 06/22/2026 at 19:12, 3 months 25 days ago Advicenne Secures Financing to Q2 2027 with New Bond Issue Strategic Development Bond Financing FDA Registration Advicenne Rare Kidney Diseases
Published on 10/17/2026 at 03:20, 1 day ago Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 1 day 1 hour ago Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 1 day 4 hours ago Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 1 day 4 hours ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 1 day 5 hours ago Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update
Published on 10/17/2026 at 18:00, 10 hours 19 minutes ago Baader Bank announces extended trading hours 23 hours a day starting Q1/2027
Published on 10/17/2026 at 13:05, 15 hours 14 minutes ago Luong Quoi Coconut Vietnam to Showcase Vietnamese Coconut Expertise at SIAL Paris 2026
Published on 10/17/2026 at 12:50, 15 hours 29 minutes ago AGFUND wins international award for excellence in inclusive banking and social impact
Published on 10/16/2026 at 20:08, 1 day 8 hours ago EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:20, 1 day 8 hours ago Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation
Published on 10/16/2026 at 18:48, 1 day 9 hours ago Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/15/2026 at 18:50, 2 days 9 hours ago September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
